Complete response of metastatic RCC with caval vein thrombus following treatment with pembrolizumab and axitinib: is it possible to extend the indications for systemic therapy?

MeSH terms

• Aged
• Antibodies, Monoclonal, Humanized* / adverse effects
• Antibodies, Monoclonal, Humanized* / therapeutic use
• Axitinib* / adverse effects
• Axitinib* / therapeutic use
• Carcinoma, Renal Cell* / drug therapy
• Carcinoma, Renal Cell* / secondary
• Female
• Humans
• Kidney Neoplasms* / drug therapy
• Kidney Neoplasms* / pathology
• Male
• Middle Aged
• Vena Cava, Inferior / pathology
• Venous Thrombosis / chemically induced
• Venous Thrombosis / drug therapy